{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:25:47Z","timestamp":1776875147163,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1136\/ard-2023-223851","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T18:20:12Z","timestamp":1675794012000},"page":"740-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["At the crossroads of inflammation and fibrosis: epiregulin"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-740X","authenticated-orcid":false,"given":"Steven","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-223851_bib1","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1093\/rheumatology\/keaa272","article-title":"Crel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis","volume":"59","author":"Worrell","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-223851_bib2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.39602","article-title":"Histone demethylation and Toll-like receptor 8-dependent cross-talk in monocytes promotes transdifferentiation of fibroblasts in systemic sclerosis via Fra-2","volume":"68","author":"Ciechomska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-223851_bib3","doi-asserted-by":"crossref","first-page":"eabq6691","DOI":"10.1126\/sciimmunol.abq6691","article-title":"Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis","volume":"7","author":"Odell","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1136\/ard-2023-223851_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.immuni.2020.06.002","article-title":"Transcriptional and functional analysis of cd1c+ human dendritic cells identifies a CD163+ subset priming CD8+CD103+ T cells","volume":"53","author":"Bourdely","year":"2020","journal-title":"Immunity"},{"key":"10.1136\/ard-2023-223851_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10067-013-2305-4","article-title":"Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities","volume":"32","author":"Xu","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-223851_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","article-title":"Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis","volume":"70","author":"Dees","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-223851_bib7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-223851_bib8","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/jid.2015.174","article-title":"Inhibition of EGFR tyrosine kinase by erlotinib prevents sclerodermatous graft-versus-host disease in a mouse model","volume":"135","author":"Morin","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard-2023-223851_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"key":"10.1136\/ard-2023-223851_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2407-7-150","article-title":"Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer","volume":"7","author":"Makris","year":"2007","journal-title":"BMC Cancer"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-223851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:27:14Z","timestamp":1737242834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724083869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0003496724083869"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-223851","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"At the crossroads of inflammation and fibrosis: epiregulin","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-223851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}